Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc., a leading biopharmaceutical company based in the United States, focuses on developing innovative treatments for dermatological conditions. Founded in 2017, Arcutis has quickly established itself in the industry with a commitment to addressing unmet medical needs in skin health. The company’s core products include topical therapies designed to treat conditions such as psoriasis and atopic dermatitis, distinguished by their unique formulation and efficacy. Arcutis has achieved significant milestones, including successful clinical trials that have positioned it as a key player in the dermatology market. With a strong emphasis on research and development, Arcutis continues to advance its portfolio, aiming to improve the quality of life for patients suffering from skin disorders.
DitchCarbon Score
How does Arcutis Biotherapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Arcutis Biotherapeutics, Inc.'s score of 13 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Arcutis Biotherapeutics, Inc.'s reported carbon emissions
Arcutis Biotherapeutics, Inc., headquartered in the US, currently does not have available carbon emissions data for recent years, as no specific emissions figures have been reported. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the absence of specific emissions data, it is important to note that many companies in the biopharmaceutical sector are increasingly focusing on sustainability and climate commitments. This includes setting science-based targets and engaging in initiatives aimed at reducing their carbon footprint. As the industry evolves, Arcutis may consider establishing measurable climate commitments to align with broader environmental goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Arcutis Biotherapeutics, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
